Roger Phipps

6.5k total citations · 2 hit papers
94 papers, 5.2k citations indexed

About

Roger Phipps is a scholar working on Orthopedics and Sports Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Roger Phipps has authored 94 papers receiving a total of 5.2k indexed citations (citations by other indexed papers that have themselves been cited), including 54 papers in Orthopedics and Sports Medicine, 48 papers in Oncology and 24 papers in Molecular Biology. Recurrent topics in Roger Phipps's work include Bone health and osteoporosis research (51 papers), Bone health and treatments (48 papers) and Bone Metabolism and Diseases (17 papers). Roger Phipps is often cited by papers focused on Bone health and osteoporosis research (51 papers), Bone health and treatments (48 papers) and Bone Metabolism and Diseases (17 papers). Roger Phipps collaborates with scholars based in United States, United Kingdom and Austria. Roger Phipps's co-authors include Frank H. Ebetino, David B. Burr, R.G.G. Russell, Matthew R. Allen, P S Richardson, Tianzhi Yang, Shuhua Bai, George H. Nancollas, Paige Martin and Viravuth P. Yin and has published in prestigious journals such as The Journal of Physiology, Journal of Applied Physiology and Annals of the New York Academy of Sciences.

In The Last Decade

Roger Phipps

94 papers receiving 5.0k citations

Hit Papers

Exosome Delivered Anticancer Drugs Across the... 2005 2026 2012 2019 2015 2005 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Roger Phipps United States 38 2.4k 2.3k 2.2k 571 540 94 5.2k
Masako Ito Japan 40 2.4k 1.0× 2.0k 0.8× 3.0k 1.4× 414 0.7× 555 1.0× 140 6.5k
Timothy R. Arnett United Kingdom 42 947 0.4× 1.5k 0.6× 2.2k 1.0× 454 0.8× 368 0.7× 85 5.7k
Hiroshi Kaji Japan 48 1.6k 0.7× 1.7k 0.7× 3.0k 1.3× 582 1.0× 368 0.7× 228 6.8k
Martina Rauner Germany 48 1.5k 0.7× 1.9k 0.8× 3.5k 1.6× 985 1.7× 432 0.8× 240 7.3k
Masahiko Sato Japan 34 2.7k 1.1× 3.0k 1.3× 2.3k 1.0× 159 0.3× 434 0.8× 144 5.7k
Jussi M. Halleen Finland 34 1.4k 0.6× 1.7k 0.7× 2.2k 1.0× 225 0.4× 318 0.6× 86 4.1k
Donald B. Kimmel United States 51 3.9k 1.6× 2.6k 1.1× 2.9k 1.3× 176 0.3× 198 0.4× 122 6.6k
T.J. Chambers United Kingdom 57 2.1k 0.9× 3.9k 1.7× 5.5k 2.5× 680 1.2× 282 0.5× 133 9.0k
Tilman D. Rachner Germany 27 1.0k 0.4× 1.4k 0.6× 2.2k 1.0× 688 1.2× 317 0.6× 74 3.9k
Martine Cohen‐Solal France 40 1.7k 0.7× 1.5k 0.7× 2.4k 1.1× 386 0.7× 269 0.5× 242 6.1k

Countries citing papers authored by Roger Phipps

Since Specialization
Citations

This map shows the geographic impact of Roger Phipps's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roger Phipps with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roger Phipps more than expected).

Fields of papers citing papers by Roger Phipps

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roger Phipps. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roger Phipps. The network helps show where Roger Phipps may publish in the future.

Co-authorship network of co-authors of Roger Phipps

This figure shows the co-authorship network connecting the top 25 collaborators of Roger Phipps. A scholar is included among the top collaborators of Roger Phipps based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roger Phipps. Roger Phipps is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yang, Tianzhi, Paige Martin, Alison Brown, et al.. (2015). Exosome Delivered Anticancer Drugs Across the Blood-Brain Barrier for Brain Cancer Therapy in Danio Rerio. Pharmaceutical Research. 32(6). 2003–2014. 813 indexed citations breakdown →
2.
Yang, Tianzhi, et al.. (2014). In vitroevaluation of optimized liposomes for delivery of small interfering RNA. Journal of Liposome Research. 24(4). 270–279. 17 indexed citations
3.
Pemmer, Bernhard, Jochen G. Hofstaetter, Florian Meirer, et al.. (2011). Increased strontium uptake in trabecular bone of ovariectomized calcium-deficient rats treated with strontium ranelate or strontium chloride. Journal of Synchrotron Radiation. 18(6). 835–841. 25 indexed citations
4.
Geoffroy, Valérie, Eleftherios P. Paschalis, Hélène Libouban, et al.. (2011). Effects of Risedronate in Runx2 Overexpressing Mice, an Animal Model for Evaluation of Treatment Effects on Bone Quality and Fractures. Calcified Tissue International. 88(6). 464–475. 4 indexed citations
6.
Fuchs, Robyn K., et al.. (2011). Bisphosphonates do not alter the rate of secondary mineralization. Bone. 49(4). 701–705. 33 indexed citations
7.
Allen, Matthew R., John Turek, Roger Phipps, & David B. Burr. (2010). Greater magnitude of turnover suppression occurs earlier after treatment initiation with risedronate than alendronate. Bone. 49(1). 128–132. 16 indexed citations
9.
Fuchs, Robyn K., Roger Phipps, & David B. Burr. (2008). Recovery of Trabecular and Cortical Bone Turnover After Discontinuation of Risedronate and Alendronate Therapy in Ovariectomized Rats. Journal of Bone and Mineral Research. 23(10). 1689–1697. 36 indexed citations
10.
Lundy, Mark W., Frank H. Ebetino, Zhidao Xia, et al.. (2007). Bisphosphonate affinity to hydroxyapatite and farnesyl pyrophosphate inhibitory potency, together, drive in vivo efficacy. Oxford University Research Archive (ORA) (University of Oxford). 4 indexed citations
11.
Lawson, Michelle A., J T Triffitt, Frank H. Ebetino, et al.. (2005). Differences in the potential binding of phosphate containing compounds to bone mineral are revealed by the novel use of hydroxyapatite column chromatography. Journal of Bone and Mineral Research. 20. 1303–1303. 1 indexed citations
12.
Lawson, Michelle A., J T Triffitt, Frank H. Ebetino, et al.. (2005). Potential bone mineral binding differences among bisphosphonates can be demonstrated by the use of hydroxyapatite column chromatography.. Oxford University Research Archive (ORA) (University of Oxford). 5 indexed citations
13.
Otomo, Hajime, Akinori Sakai, Satoshi Ikeda, et al.. (2004). Regulation of mineral-to-matrix ratio of lumbar trabecular bone in ovariectomized rats treated with risedronate in combination with or without vitamin K2. Journal of Bone and Mineral Metabolism. 22(5). 404–14. 27 indexed citations
14.
Henneman, Zachary J., Ruikang Tang, George H. Nancollas, et al.. (2003). Bisphosphonate bone affinity, differences predicted by in vitro carbonated apatite model.. Journal of Bone and Mineral Research. 18. 1 indexed citations
15.
Nancollas, George H., et al.. (2002). Mineral binding affinities and zeta potentials of bisphosphonates. Journal of Bone and Mineral Research. 17. 8 indexed citations
16.
Nancollas, George H., Ahmed H. Mangood, Weiming Wu, et al.. (2002). Mineral binding affinities of bisphosphonates.. Bone. 30. 11 indexed citations
17.
Nancollas, George H., Ahmed H. Mangood, Weijie Wu, et al.. (2002). Comparative mineral binding affinities of selected bisphosphonates. Osteoporosis International. 13. 2 indexed citations
18.
Ebetino, Frank H., James E. Dunford, Roger Phipps, et al.. (2002). Modeling of bisphosphonate binding to farnesyl diphosphate synthase. Bone. 30. 3 indexed citations
19.
Phipps, Roger, et al.. (1986). Development of ion transport and glycoprotein secretion in sheep trachea. Fed. Proc., Fed. Am. Soc. Exp. Biol.; (United States). 2 indexed citations
20.
Chu, Chia‐Yu, et al.. (1980). Nail involvement in Darier's disease: a case report. Journal of the American Podiatric Medical Association. 70(12). 635–636. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026